The Role of Oral Antiplatelet Agents in Atherothrombotic Disease

Author： Ferguson James J.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.3, 2006-01, pp. : 149-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

By Ling Geoffrey  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 197-209

Adis International

Access to resources Recommend Favorite

Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4610-4616

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 850-860

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

By Colwell John A.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke

By  

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1377-1391

Bentham Science Publishers

Access to resources Recommend Favorite